Rating History for Jounce Therapeutics (JNCE) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for JNCE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/27/2023 Edward Tenthoff Downgrade Neutral
(N/A)		 1.85
(N/A)		 1.51
(1.88)		 24.5% Details